Ciprofloxacin (BAY O 9867). Comparative in vitro activity study.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002939:Ciprofloxacin; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D066298:In Vitro Techniques; D009268:Nalidixic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D009582:Nitrofurantoin / Q000494:pharmacology; D009643:Norfloxacin; D010876:Pipemidic Acid / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D011804:Quinolines; D009268:Nalidixic Acid; D002939:Ciprofloxacin; D009582:Nitrofurantoin; D010876:Pipemidic Acid; D009643:Norfloxacin